Exact Mass: 217.0714
Exact Mass Matches: 217.0714
Found 199 metabolites which its exact mass value is equals to given mass value 217.0714,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Captopril
Captopril is a potent, competitive inhibitor of angiotensin-converting enzyme (ACE), the enzyme responsible for the conversion of angiotensin I (ATI) to angiotensin II (ATII). ATII regulates blood pressure and is a key component of the renin-angiotensin-aldosterone system (RAAS). Captopril may be used in the treatment of hypertension. C - Cardiovascular system > C09 - Agents acting on the renin-angiotensin system > C09A - Ace inhibitors, plain > C09AA - Ace inhibitors, plain D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors > D000806 - Angiotensin-Converting Enzyme Inhibitors C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials C471 - Enzyme Inhibitor > C783 - Protease Inhibitor > C247 - ACE Inhibitor D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
(2S)-3-(3-Carbamoyloxiranylcarbonylamino)-2-aminopropanoic acid
(R)-3-(indol-3-yl)-2-oxobutyric acid
The (R)-enantiomer of 3-(indol-3-yl)-2-oxobutyric acid.
1-(D-3-Mercapto-2-methyl-1-oxopropyl)-L-proline
4-Ethoxymethylene-2-phenyl-2-oxazolin-5-one
D007155 - Immunologic Factors
3,4-Dihydro-2H-pyrimido[1,2-c][1,3]benzothiazin-6-imine
N-[(2R)-4-(Hydroxymethyl)-3-oxo-1-sulfanylhex-4-en-2-yl]acetamide
5-(2-Cyanoethyl)-2-mercapto-4,6-dimethylnicotinonitrile
7-Methoxy-1,6-dimethyl-5,8-dihydroisoquinoline-5,8-dione
2,4-dihydro-4-(beta-D-ribofuranosyl)-1,2,4(3H)-triazol-3-one|4-beta-D-Ribofuranosyl-1,2,4-triazol-3(2H)-one|4-beta-D-ribofuranosyl-1,2,4-triazolin-3-one
Captopril
C - Cardiovascular system > C09 - Agents acting on the renin-angiotensin system > C09A - Ace inhibitors, plain > C09AA - Ace inhibitors, plain D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors > D000806 - Angiotensin-Converting Enzyme Inhibitors C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials C471 - Enzyme Inhibitor > C783 - Protease Inhibitor > C247 - ACE Inhibitor D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS Annotation level-1 CONFIDENCE standard compound; INTERNAL_ID 2721 CONFIDENCE standard compound; INTERNAL_ID 8619
1,6-Dimethyl-4-oxo-1,4-dihydro-quinoline-3-carboxylic acid
methyl 4-methyl-1-oxo-2H-isoquinoline-3-carboxylate
4-Isoxazolecarboxaldehyde,3-(4-methoxyphenyl)-5-methyl-(9CI)
1-(2-(DIMETHYLAMINO)PHENYL)-2,2,2-TRIFLUOROETHANONE
METHYL 2-METHYL-4-OXO-1,4-DIHYDROQUINOLINE-6-CARBOXYLATE
Tinazoline
C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C72900 - Adrenergic Antagonist
(Z)-4-(4-METHOXYBENZYLIDENE)-2-METHYLOXAZOL-5(4H)-ONE
4-ISOXAZOLECARBOXYLIC ACID, 5-METHYL-3-(4-METHYLPHENYL)-
1,4-Dihydro-1,2-dimethyl-4-oxo -3-quilinecarboxylic acid
1-(2-DIBENZYLAMINO-4-METHYL-THIAZOL-5-YL)-3-(2,5-DIHYDRO-2-DIBENZYLIMMONIUM-4-METHYL-THIAZOL-5-YLIDENE)-2-OXO-CYCLOBUTEN-4-OLATE
2-(1-methylidene-3-oxoisoindol-2-yl)propanoic acid
2-(1-METHYL-1H-INDOL-3-YL)-2-OXOACETIC ACID METHYL ESTER
4-(2,3-dihydroimidazo[2,1-b][1,3]thiazol-6-yl)aniline
5,8-DIMETHYL-4-HYDROXYQUINOLINE-3-CARBOXYLIC ACID
Phosphonic acid, (1-aminoethyl)-, diethyl ester, hydrochloride, (R)- (9CI)
1-(4-(DIMETHYLAMINO)PHENYL)-2,2,2-TRIFLUOROETHANONE
1-(3-(DIMETHYLAMINO)PHENYL)-2,2,2-TRIFLUOROETHANONE
2-(1-Methyl-2-oxopropyl)-1H-isoindole-1,3-(2H)-dione
4-Quinolinecarboxylicacid, 1,2-dihydro-2-oxo-, ethyl ester
5-(3-aminophenyl)furan-2-carboxylic acid methyl ester
Spiro[cyclohexane-1,3(1H)-furo[3,4-c]pyridine]-1,4-dione
5-(2-AMINO-PHENYL)-FURAN-2-CARBOXYLIC ACID METHYL ESTER
1-ethyl-4-oxo-1,4-dihydroquinoline-3-carboxylic acid(SALTDATA: FREE)
2,2,2-TRIFLUORO-N-[(R)-ALPHA-METHYLBENZYL]ACETAMIDE
3-METHYL-5-PHENYL-ISOXAZOLE-4-CARBOXYLIC ACID METHYL ESTER
1-(3-fluoro-4-Methoxyphenyl)cyclopropanamine hydrochloride
methyl 4-methyl-2-phenyl-1,3-oxazole-5-carboxylate
2,2,2-TRIFLUORO-N-[(S)-ALPHA-METHYLBENZYL]ACETAMIDE
4-ISOXAZOLECARBOXYLIC ACID, 5-METHYL-3-PHENYL-, METHYL ESTER
1-((2,3-DIHYDROBENZO[B][1,4]DIOXIN-2-YL)METHYL)HYDRAZINE
3-(5,6-Dihydroimidazo[2,1-b][1,3]thiazol-6-yl)aniline
Epicaptopril
D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors > D000806 - Angiotensin-Converting Enzyme Inhibitors D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents
3,4-Dihydro-2H-pyrimido[1,2-c][1,3]benzothiazin-6-imine
4-ethoxymethylene-2-phenyl-2-oxazolin-5-one
D007155 - Immunologic Factors
1-(3-Mercapto-2-methyl-propionyl)-pyrrolidine-2-carboxylic acid
N-3-(R,R)-epoxysuccinamoyl-(S)-2,3-diaminopropanoate
(2S)-3-azaniumyl-2-[(3-carbamoyloxirane-2-carbonyl)amino]propanoate
N-(S,S)-3-epoxysuccinamoyl-(S)-2,3-diaminopropanoate
(2S)-3-amino-2-[(3-carbamoyloxirane-2-carbonyl)amino]propanoic acid
(S)-2-Amino-3-[[(2R,3R)-3-carbamoyloxirane-2-yl]carbonylamino]propionic acid
(2S)-2-amino-3-[[(2S,3S)-3-carbamoyloxirane-2-carbonyl]amino]propanoic acid
N-[(2R)-4-(Hydroxymethyl)-3-oxo-1-sulfanylhex-4-en-2-yl]acetamide
3-[[[(2R,3R)-3-carboxyoxiran-2-yl]carbonyl]amino]-L-alanine
3-amino-N-(trans-3-carbamoyloxirane-2-carbonyl)-L-alanine
A dicarboxylic acid diamide consisting of 3-aminoalanine in which the alpha-amino fuunction is acylated by a 3-carbamoyloxirane-2-carbonyl group. NB Although the relative configuration of the epoxide moiety has been assigned as trans, it has not yet been established whether the absolute configuration is R,R (as drawn) or S,S.
3-amino-N-(trans-3-carbamoyloxirane-2-carbonyl)-L-alanine zwitterion
An amino acid zwitterion obtained by transfer of a proton from the carboxy to the amino group of 3-amino-N-(trans-3-carbamoyloxirane-2-carbonyl)-L-alanine; major species at pH 7.3. NB Although the relative configuration of the epoxide moiety has been assigned as trans, it has not yet been established whether the absolute configuration is R,R (as drawn) or S,S.
6-(4-hydroxy-2,5-dihydro-1,3-thiazol-2-yl)hexanoic acid
2-amino-3-[(2-diazo-3-hydroxybutanoyl)oxy]propanoic acid
4-ethoxycarbonyl-2-quinolinone
{"Ingredient_id": "HBIN010377","Ingredient_name": "4-ethoxycarbonyl-2-quinolinone","Alias": "NA","Ingredient_formula": "C12H11NO3","Ingredient_Smile": "CCOC(=O)C1=CC(=O)NC2=CC=CC=C21","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "SMIT15322","TCMID_id": "7397","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
